Helicobacter pylori infects approximately 50% of the world's population and is considered
the major etiological agent of severe gastric diseases, such as peptic ulcers and gastric …

This review covers the current knowledge and gaps in Helicobacter pylori
lipopolysaccharide (LPS) structure and biosynthesis. H. pylori is a Gram‐negative bacterium …

Helicobacter pylori has a unique lipopolysaccharide structure that is essential in maintaining
its cell envelope integrity and imbues the bacterium with natural resistance to cationic …

Helicobacter pylori lipopolysaccharide promotes chronic gastric colonisation through O-
antigen host mimicry and resistance to mucosal antimicrobial peptides mediated primarily by …

Helicobacter pylori colonises the gastric mucosa of humans. The majority of organisms live
in mucus. These organisms are an important reservoir for infection of the underlying …

Helicobacter pylori produces a unique surface lipopolysaccharide (LPS) characterized by
strikingly low endotoxicity that is thought to aid the organism in evading the host immune …

Escherichia coli (E. coli) are one of the pathogenic bacterias of cow mastitis, which mainly
triggers systemic symptoms by releasing lipopolysaccharide (LPS). The waaF is the core …

The trefoil peptides (TFF1, TFF2 and TFF3) are a family of small highly conserved proteins
that play an essential role in epithelial regeneration within the gastrointestinal tract, where …

The lipid A of Gram-negative bacteria plays a major role in the pathogenesis of bacterial
infections. Lipid A diversity is observed both in the number and length of fatty-acid side …

The outer core region of Helicobacter pylori lipopolysaccharide of the majority of isolates
contains an α-1, 6-glucan polymer synthesized by the product of the HP0159 ORF. Structural …